Oramed Pharmaceuticals ORMP
NASDAQ ORMP
$4.14 -0.01 (-0.24%)
At close: Oct 21, 2026 · 4:00 PM EDT

Oramed Pharmaceuticals (ORMP) Interest Coverage Ratio (2023 - 2024)

Updated

Oramed Pharmaceuticals' (ORMP) Interest Coverage Ratio was -14.98 for FY2024, compared with -7.74 in FY2023.

Analysis

Oramed Pharmaceuticals (ORMP) Interest Coverage Ratio (2023 - 2024) Analysis & Trends

  • According to Business Quant data, Interest Coverage Ratio came in at -7.74 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 25.41
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 10.28
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 7.27
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 5.22
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -42.08
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Oramed Pharmaceuticals 169.50 Mn -165.24 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -12.01
Mar 31, 2024 -5.00
Dec 31, 2023 -3.20
Sep 30, 2023 -3.50
API Access

Oramed Pharmaceuticals Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=ORMP&period=max&api_key=YOUR_API_KEY